The accumulating clinical evidence, while still evolving, provides a solid foundation for the continued development of SFN as both a chemopreventive agent and therapeutic adjunct
Am J Physiol Cell Physiol (2004) 286(1):C13844.10.1152/ajpcell.00114.2003 207 SotiropoulosAOhannaMKedziaCMenonRKKopchickJJKellyPAet alGrowth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation
Gastrointestinal distress is common
Life Sci 267:118954 Furino VDO, Alves JM, Marine DA, Sene-Fiorese M, Rodrigues CNDS, Arrais-Lima C, Mattiello SM, Castro CAD, Borra RC, Rocha MC, Malavazi I, Duarte ACGDO (2021) Dietary intervention, when not associated with exercise, upregulates irisin/FNDC5 while reducing visceral adiposity markers in obese rats
Because both act on different pituitary receptors, their effect does not merely add up, it potentiates